Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

Bio Essence (BIOE) Shares Issued (2020)

Bio Essence has reported Shares Issued over the past 1 years, most recently at -$100000.0 for Q1 2020.

For Q1 2020, Shares Issued changed N/A year-over-year to -$100000.0; the TTM value through Dec 2020 reached -$100000.0, changed N/A, while the annual FY2020 figure was -$100000.0, N/A changed from the prior year.
Shares Issued for Q1 2020 was -$100000.0 at Bio Essence.
Over five years, Shares Issued peaked at -$100000.0 in Q1 2020 and troughed at -$100000.0 in Q1 2020.